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ABSTRACT 38 
In this study, we investigated the in vitro ACE inhibitory and in vivo antihypertensive effect 39 
of insect cell extracts. The IC50 of three insect cell lines from different type and insect species 40 
origin: S2 (embryo, Drosophila melanogaster), Sf21 (ovary, Spodoptera littoralis) and Bm5 41 
(ovary, Bombyx mori), were evaluated. Most interesting results were that the IC50 values 42 
ranged between 0.4-0.9 mg/ml, and that an extra hydrolysis with gastrointestinal enzymes did 43 
not increase the ACE inhibitory activity conspicuously. Finally, a single oral administration 44 
with a gavage of 150 mg cell extract/kg BW to spontaneous hypertensive rats (SHR) 45 
significantly decreased (p < 0.05) their systolic blood pressure (SBP) with 5-6% (9-12 mm 46 
Hg) compared to the controls at 6 h post-administration. Here the undigested and digested 47 
insect S2 cell extracts were equal in activity to lower the SBP. To the best of our knowledge, 48 
this is the first report of in vivo antihypertensive activity of insect cell extracts and this 49 
without an extra digestion requirement.  50 
 51 
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INTRODUCTION 55 
 56 
Hypertension or high blood pressure [systolic blood pressure (SBP) >140 mm Hg or diastolic 57 
blood pressure >90 mm Hg] is an important worldwide problem and forms an important risk 58 
factor for the development of cardiovascular diseases [21]. Cardiovascular diseases are one of 59 
the major causes of death in the Western world [12]. High blood pressure nowadays is treated 60 
by a combination of antihypertensive medication and a healthier lifestyle [15]. Blood pressure 61 
is regulated by several mechanisms and one of these mechanisms is the renin-angiotensin-62 
aldosteron system (RAAS) which involves the angiotensin converting enzyme (ACE), a zinc 63 
metallopeptidase. ACE increases blood pressure via two major pathways: it converts the 64 
inactive angiotensin I into angiotensin II, a vasoconstrictor, and breaks down bradykinin, a 65 
vasodilator [30].  66 
To date, synthetic ACE inhibitors like captopril are widely used, but these may cause 67 
severe side effects like cough and angio-oedema [3]. In this context the ambition exists that 68 
some food proteins possess the ability to release ACE inhibitory peptides after hydrolysis 69 
[14,42]. Such peptides might form an ingredient for functional foods or nutraceuticals which 70 
might be an alternative for the use of medication or might postpone its use. 71 
In the continuation of our research with insects, we have recently shown the unique 72 
concept that insects can serve as a source for ACE inhibitory peptides [38,39,41]. 73 
Interestingly, insects are being used for human consumption in a wide range of regions over 74 
the world [5,11,32]. Hence, Vercruysse et al. [37] reported that enzymatic hydrolysis is 75 
important and necessary for releasing bioactive peptides with ACE inhibitory activity. For 76 
example gastrointestinal digestion of a protein extract of silk moth Bombyx mori caterpillars, 77 
using pepsin, trypsin and chymotrypsin, decreased the IC50 values about 100 fold; namely 78 
from 73 mg/ml, which represents a very low to no activity, to 0.7 mg/ml, representing high 79 
5 
 
activity [38]. Besides, the potency of the ACE inhibitory peptides from insect protein 80 
hydrolysate was confirmed in vivo [41]. However, it needs to be mentioned that a mass 81 
culture maintenance of whole insects is posing different disadvantages such as high labor 82 
costs for insect feeding and cleaning of the cages on a regularly basis, insect health concerns, 83 
exploitation facilities and permits [10,11]. It can therefore be proposed to use insect cell 84 
cultures as a valuable alternative source of insect protein/polypeptides [43]. Indeed, insect 85 
cells can be cultured in standardized biotechnology bioreactors, in suspension or immobilized 86 
on substrates, to create a large biomass [1,13,33,47], and they can so be used as a food and 87 
protein source [43]. Another advantage of insect cell cultures over whole insects is the 88 
characteristic of a very homogenous product with a stable quality and high protein content.  89 
This paper describes the antihypertensive capacity of insect cells based on ACE 90 
inhibition. At first, the potential of a protein extract of different insect cells to inhibit ACE 91 
activity was tested in vitro. Three different cells lines and types were selected: (a) the dipteran 92 
Drosophila melanogaster S2 cells that are from embryonic origin and can be characterized as 93 
small, round and fast growing, (b) the lepidopteran Bombyx mori Bm5 cells that are from 94 
ovarian origin and typically large, and (c) the ovarian cloned Sf21 cells of the fall armyworm 95 
Spodoptera frugiperda that are widely used in biotechnology industry for in vitro production. 96 
Second, we investigated the benefit of hydrolysis to increase ACE inhibitory activity by 97 
release of more bioactive peptides from the protein extract. Based on Vercruysse et al. [37] 98 
we employed a gastrointestinal digestion protocol with use of pepsin, trypsin and 99 
chymotrypsin as this was found to work best with insect protein extracts. In a final step, the 100 
antihypertensive effect of the insect cell extracts was measured in vivo using spontaneously 101 
hypertensive rats (SHR) to support their potential use in lowering blood pressure at organism 102 
level.  103 
 104 
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MATERIALS AND METHODS 105 
 106 
Products 107 
Pepsin, trypsin, α-chymotrypsin, hippuryl-L-histidyl-L-leucine (HHL), ACE (from rabbit 108 
lung), o-pthaldialdehyde (OPA), antibiotics (antibiotic-antimycotic stabilized (AAS) contains 109 
10000 units/ml penicillin G, 10 mg/ml streptomycinsulfate and 25 µg/ml amphotericine B), 110 
IPL-41 insect medium, tryptose phosphate, sucrose, ZnSO4.7H2O, AlK(SO4)2, cytochrome C, 111 
insulin, substance P and Val-Tyr were purchased from Sigma-Aldrich (Bornem, Belgium; St. 112 
Louis, IL). SFX insect medium was purchased from Hyclone (Logan, UT). Fetal bovine 113 
serum (FBS) was purchased from Invitrogen (Carlsbad, CA).  114 
 115 
Insect cell cultures 116 
The insect cell lines S2 [34]  and Sf21 [37], that originated from the embryo of the fruitfly (D. 117 
melanogaster, Diptera) and from ovarian tissue of the fall armyworm (S. frugiperda, 118 
Lepidoptera), respectively, were cultured in SFX medium with 10 ml AAS/l. The Bm5 cell 119 
line that originated from B. mori ovary (Lepidoptera) [35] was kept in IPL-41 medium, 120 
supplemented with 10% FBS, 2.6 g/l tryptose phosphate, 9.0 g/l sucrose, 0.069 mg/l 121 
ZnSO4.7H2O, 7.59 mg/l AlK(SO4)2 and 10 ml/l AAS at pH 6.3. All cells were incubated at 122 
27°C.  123 
 124 
Preparation of protein/polypeptide extracts from insect cells, including hydrolysis with 125 
gastrointestinal enzymes 126 
After insect cell harvesting by gentle centrifugation (300 g, 20 min), the pelleted cells were 127 
resuspended in distilled water, and then frozen and thawed for obtaining a cell protein extract. 128 
The resulting extract was lyophilized.  129 
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For a gastrointestinal digestion with pepsin (pH 2) followed by trypsin/α-130 
chymotrypsin (pH 6.5), that was found as best to release ACE bioactive peptides of whole 131 
insects and increase ACE inhibitory activity [37], the powdered lyophilized 132 
protein/polypeptide insect cell extracts as obtained above were dissolved in distilled water 133 
(200 mg of sample in 5 ml distilled water), the pH was lowered to 2 (HCl, 0.1 M), pepsin was 134 
added (1 g enzyme per 250 g of sample), and the solution was incubated for 2.5 h at 37°C. 135 
Subsequently, the pH was set at 6.5 (NaOH, 0.1 M), trypsin and α-chymotrypsin were added 136 
(1 g enzyme per 250 g of sample) and after incubation for 2.5 h at 37°C, the solution was 137 
heated to 80°C for 15 min to stop the enzymatic reaction, and the resulting hydrolysate was 138 
lyophilized as previously described [37].  139 
 140 
ACE inhibitory activity in vitro 141 
ACE inhibitory activity was measured according to the colorimetric method of Chang et al. 142 
[8] with slight modifications. In brief, the substrate hippuryl-histidyl-leucine (HHL) is 143 
cleaved by ACE into hippuric acid (H) and L-histidyl-L-leucine (HL). At pH >11, the 144 
dipeptide HL reacts with o-phtaldialdehyde (OPA) forming a yellowish product, of which the 145 
absorbance can be measured at 390 nm. The ACE catalyzed reactions were performed in 146 
cuvettes containing 100 μl of sample solution (containing the powdered lyophilized 147 
protein/polypeptide insect cell extracts), 100 μl of ACE solution, and 100 μl of HHL solution 148 
for 2 h at 37°C. The enzymatic reactions (pH 5-10) were terminated by adding 2 ml of the 149 
alkaline OPA reagent. Absorbance was measured after 20 min-incubations at 25°C.  150 
Concentration-response curves were generated for the logarithm of the concentration of the 151 
sample (mg/ml) versus ACE inhibitory activity (%) with use of the nonlinear sigmoid 152 
regression in Prism v4 software (GraphPad Prism, La Jolla, CA); the goodness of fitness was 153 
evaluated based on R
2
.  The IC50 values, referring to the concentration of sample inhibiting 154 
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50% of ACE activity, together with corresponding 95% confidence limits (95% CL), were 155 
calculated as previously described [38]. The concentration-response curves are made with 10 156 
concentrations of sample, and each value is expressed as mean ± SD based on 3 repeated 157 
measurements.  158 
 159 
Peptide profile with gel filtration chromatography 160 
Peptide samples were analyzed with use of a Superdex Peptide HR 10/30 column (Alltech 161 
Associates, Lokeren, Belgium) coupled to a UV detector (Thermo Surveyor Finnigan, 162 
Spectralab Scientific Inc., Toronto, Canada), measuring at 214 nm. The elution buffer (0.02 163 
M NaH2PO4.2H2O, 0.25 M NaCl, pH 7.2) was pumped through the column at a flow rate of 164 
0.5 ml/min. The samples were dissolved in elution buffer (10 mg lyophilized powder/ml) and 165 
injected with a loop of 50 µl. The column was calibrated with cytochrome C (12500 kDa), 166 
insulin (5777 Da), substance P (1348 Da) and Val-Tyr (280 Da). 167 
 168 
Antihypertensive effect with SHR in vivo 169 
Male SHR of 10-14 weeks old and a fresh weight of 230-310 g were purchased from Harlan 170 
(Horst, the Netherlands), and housed in steel cages in a climatized room kept at 24°C with a 171 
12 h dark-light cycle. They were fed a standard laboratory diet and tap water was freely 172 
available. The powdered lyophilized protein/polypeptide insect cell extracts as obtained above 173 
were dissolved in 0.5 ml of tap water at a dose of 150 mg per kg body weight (BW), and 174 
treated orally using a plastic gavage. Control rats were administered the same volume of tap 175 
water. Following oral administration with use of a gavage (0 h), the SBP was measured in 176 
conscious restrained rats after 2, 4, 6, 8 and 24 h by the tail-cuff method with a piezoelectric 177 
pneumatic pulse transducer [24]. The change of the SBP since time 0 h was expressed as 178 
mean ± SEM based on 3 measurements with 6 SHR for each sample (undigested and digested 179 
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insect cell extract) and 9 SHR for the control. The significance of differences between 180 
treatments and the controls was calculated with ANOVA and means were separated by a post 181 
hoc Tukey test (S-Plus, TIBCO software Inc., Palo Alto, CA). These experiments were 182 
approved by the ethical committee for animal experiments of the Faculty of Medicine and 183 
Health Sciences, Ghent University. 184 
 185 
RESULTS 186 
 187 
Potency of different insect cells to inhibit ACE 188 
In this project three different insect cell lines S2 (D. melanogaster), Sf21 (S. littoralis) and 189 
Bm5 (B. mori) were evaluated for their ACE inhibitory activity in vitro. The insect cells were 190 
homogenized by freezing and thawing. As depicted in Fig. 1, the median effect concentrations 191 
(IC50) of the three different undigested insect cell extracts to inhibit ACE ranged between 0.7-192 
0.9 mg lyophilized cell extract per ml, and were not significantly different based on 193 
overlapping 95% CL.  194 
 195 
Need for extra hydrolysis with use of insect cells as protein source to inhibit ACE 196 
A gastrointestinal digestion was applied to the insect cell extracts of the three different cell 197 
lines. The calculated IC50 values of the digested insect cell extracts to inhibit ACE ranged 198 
between 0.4-0.7 mg lyophilized cell extract per ml. They have overlapping/touching 95% CL 199 
with the IC50 values of the undigested insect cell extracts (Fig. 1).  200 
On the water extraction by freezing and thawing, we can confirm that this resulted in a 201 
chromatographic peptide profile with most proteins/peptides being bigger than 5 kDa; 202 
however some small peptide peaks (ranging between 150-500 Da) were present, as seen for 203 
S2 cells in Fig. 2. A similar peptide profile was observed for Bm5 and Sf21 cells (data not 204 
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shown). In addition, the extra gastrointestinal digestion with pepsin and trypsin/α-205 
chymotrypsin caused a clear shift to more and smaller peptides, confirming effective (further) 206 
cleavage of the protein/polypeptide fraction. As depicted in Fig. 2, most peptides after 207 
digestion had a molecular weight below 5 kDa with S2 cells and this concurred with a higher 208 
fraction of polypeptides/peptides ranging between 150-500 g/mol. This trend was also found 209 
for Bm5 and Sf21 cells (data not shown).  210 
 211 
Antihypertensive activity of insect cell extracts in SHR in vivo 212 
SHR is an accepted animal model to evaluate the antihypertensive effect of components with 213 
ACE inhibitory activity. To test the antihypertensive effect of the insect cells, the change in 214 
SBP of SHR after oral administration of extracts of S2 D. melanogaster cells was measured. 215 
We selected to work with S2 cells as the ACE inhibitory activity seemed independent of cell 216 
type and insect species (see above) and S2 cells are fast growing, which allows a rapid 217 
collection of a high biomass amount of insect cell extract for testing on SHR. The basal SBP 218 
measured at time point zero in SHR was 178 ± 3 mm Hg. As depicted in Fig. 3, the change in 219 
SBP after a single oral administration of undigested S2 cell extract at 150 mg/kg BW tended 220 
(p = 0.051) already to be lower as compared to the control (ΔSBP of about 6 mm Hg) after 4 221 
h, and was significant at 6 h (p = 0.003: 9 ± 3 mm Hg on 178 mm Hg, representing 5% 222 
decrease) and at 8 h (p = 0.03; 6 ± 4 mm Hg on 178 mm Hg, representing 3% decrease) post-223 
administration. Also the S2 cell extract after an extra gastrointestinal digestion was tested 224 
with one single dose at 150 mg/kg BW in SHR, and the ΔSBP curve for the digested sample 225 
demonstrated a high activity (Fig. 3). At 4 h post-administration, the SBP was significantly (p 226 
= 0.02) lowered compared to the water-treated controls and the effect increased during the 227 
course of the experiment. After 6 h, the significant (p = 0.0007) decrease in SBP yielded 12 ± 228 
3 mm Hg, which represents a decrease of 6%, and the effect remained also at 8 h (p = 0.009). 229 
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The decrease in blood pressure caused by the digested S2 cell extract was not significantly 230 
different from that of the undigested S2 cell extract (p > 0.05). 231 
 232 
DISCUSSION 233 
 234 
In this project we investigated the ACE inhibitory potential of water extracts of three different 235 
insect cell lines (i.e. S2, Sf21 and Bm5), resulting in IC50 values ranging between 0.7-0.9 236 
mg/ml. These values are low enough to be considered as biologically active against ACE 237 
[6,9,18-20,36,45,46]. Interestingly, the three IC50 values for the undigested water extracts of 238 
the insect cell lines of the three insect species were not significantly different, suggesting that 239 
insect cell extracts possess the potential to inhibit ACE independent of cell type and insect 240 
species origin. As compared to previous experiments with use of whole insect body extracts 241 
where for instance IC50 values of 22.5 mg/ml for bumblebees Bombus terrestris, 12.4 mg/ml 242 
for locusts Schistocerca gregaria, and 6.3 mg/ml for armyworms Spodoptera littoralis were 243 
obtained [38], the IC50 values of insect cell extracts are much lower. To explain the higher 244 
activity with use of insect cells, it should be mentioned that cell cultures contain relatively 245 
higher amounts of protein per biomass as compared to whole insect bodies which contain 246 
highly sclerotized cuticle parts like mouthparts, legs, wings and other low-protein parts [23]. 247 
In addition, we speculate that the protein/polypeptide fraction of insect cell lines is more 248 
ready available. In insect cells for instance the extraction matrix is free of the whole body 249 
exoskeleton that contains high amounts of proteins but which are complexed in the chitin 250 
polymerized matrix [22,27]. Besides, it is reasonable that intracellular enzymes, which can be 251 
activated during the homogenization by freezing and thawing, cleave proteins/polypeptides 252 
resulting in ACE inhibitory peptides. However, to date little is known about such enzymes in 253 
insect cells. As a consequence, we envisage that future research can be of interest to indicate 254 
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which insect cell-related enzymes are responsible for generating a high ACE inhibitory 255 
activity. In conclusion, the present results provide strong evidence that a relatively simple 256 
water extraction of insect cells possesses high ACE inhibitory activity and this is suggested to 257 
be independent of the cell type and insect species origin. These findings are very promising 258 
for using insect cells as a dietary protein source to help control hypertension.  259 
In a recent study of Vercruysse et al. [37] enzymatic hydrolysis of whole insects was 260 
necessary to obtain a significant increase, ranging between 5 and 100 fold, of ACE inhibitory 261 
activity. In the latter study, the simulated human digestion by gastrointenstinal enzymes with 262 
pepsin at pH 2 followed by trypsin/ α-chymotrypsin at pH 6.5 was found the best with an 263 
increase in activity of nearby 100 fold. Similarly, other authors confirmed the necessity of 264 
enzymatic hydrolysis with for instance thermolysin, proteinase A, alcalase, collagenase 265 
[4,7,16,17,29,31] and the great potential of gastrointestinal digestion [2,25,26] to obtain a 266 
bioactive hydrolysate/peptide fraction for ACE inhibition. Interestingly, an extra hydrolysis of 267 
the insect cell extracts only caused a minor improvement of the ACE inhibitory activity, as 268 
the IC50 values ranged between 0.4-0.7 mg/ml. This is in great contrast to many previous 269 
reports in the recent decade [4,17,28,29,31,36,38,44,45] that confirmed that an enzymatic 270 
hydrolysis of food protein is an important step for obtaining ACE inhibitory activity. 271 
Although the values of the digested insect cell extracts are very close to the IC50 values of the 272 
undigested insect cell extracts as they have touching/overlapping 95% CL, the current results 273 
suggest that the maximum ACE inhibitory potential of the insect cell extracts is not fully 274 
exploited yet with a simple water extraction by freezing and thawing. Future research can 275 
focus on the optimization of the extraction procedure with an extra hydrolysis step of the 276 
insect cells to increase the activity. However, this increase will probably only be to a limited 277 
extent, since as stated above, cell cultures contain high amounts of protein that are readily 278 
available for digestion by cell-related enzymes during the water extraction. Taken together, 279 
13 
 
these results demonstrated that an extra hydrolysis is not essential to obtain an ACE inhibitory 280 
activity. 281 
Next to in vitro activity for ACE inhibition, the antihypertensive potential of the 282 
undigested and digested insect S2 cell extracts was also investigated in vivo with SHR. The 283 
maximum decrease in blood pressure after a single oral administration amounted to 5-6% 284 
against the baseline. Indeed it was of great interest in this project that the effects of 285 
nondigested and digested S2 cell extracts were significantly equal over the course of the 286 
experiment. These results are in accordance with the expectations based on the IC50 values 287 
from our in vitro ACE inhibition tests. So in conclusion the results of this project 288 
demonstrated that a water-based protein extract of insect S2 cells exerts in vivo 289 
antihypertensive activity after a single oral administration and that hydrolysis is not a 290 
necessity to release the antihypertensive peptides. Moreover, the equal antihypertensive 291 
effects of the undigested and digested S2 cell extracts confirm that the ACE inhibitory 292 
peptides are (at least in part) resistant to the rat gastrointestinal digestion. However, it should 293 
also be mentioned here that we believe that it cannot absolutely be excluded that also other 294 
components than peptides can be present in the insect cell extracts and that they are involved 295 
in ACE activity and/or other blood pressure regulatory mechanisms. Here, we envisage that 296 
long term administration of the insect cell extracts to SHR is important. Studies with long 297 
term administration could provide more information whether the effect on blood pressure is 298 
directly linked with/influenced by ACE inhibition and/or other blood pressure regulating 299 
mechanisms as other factors could be evaluated such as the sodium in the urine, the organ 300 
weight (liver, kidney, heart and lungs) and serum ACE activity [40,41]. In addition, 301 
identification of the bioactive peptides in the insect cell extracts would help to confirm or 302 
generate new lead structures for ACE inhibition and antihypertension and potentially other 303 
biologically innovative physiological events.  304 
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In conclusion, to the best of our knowledge, this is the first report of in vivo 305 
antihypertensive activity of insect cell extracts and this without requirement of an extra 306 
digestion. As a consequence, our results confirm the potential of insect cells, which can easily 307 
be cultured in industrial bioreactors to obtain high biomass amounts, as a source of bioactive 308 
peptides for functional foods or nutraceuticals with antihypertensive activity. 309 
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Figure legends 440 
 441 
Fig. 1 – (A) Sigmoid concentration-response curves for ACE inhibition with 442 
protein/polypeptide water extracts of the three insect cell lines, S2, Sf21 and Bm5, when 443 
extracted by freezing and thawing (undigested) and after an extra gastrointestinal digestion 444 
(digested). The concentration-response curves are made with 10 concentrations of sample, and 445 
each value is expressed as mean ± SD based on 3 repeated measurements. (B) Tabulated IC50 446 
values (in mg/ml) for undigested and digested extracts of the three insect cell lines (S2, Sf21 447 
and Bm5) together with corresponding 95% confidence limits (95% CL), and the R² as 448 
goodness of fitness for each concentration-response curve.  449 
 450 
Fig. 2 - Chromatographic profiles of undigested and digested S2 cells with Superdex Peptide 451 
column. Absorbance was measured at 214 nm. 452 
 453 
Fig. 3 - Change in SBP with use of spontaneous hypertensive rats (SHR) after a single oral 454 
administration of 0.5 ml of tap water (control, n = 9), undigested and digested S2 cell extract 455 
(150 mg/kg BW dissolved in 0.5 ml tap water, n = 6). Values with different letters (a, b) 456 
indicate a significant difference (p < 0.1) between values at the same time point calculated 457 
with ANOVA followed by a post hoc Tukey test (df = 2; 2 h: F = 0.28, p = 0.75; 4 h: F = 458 
2.36, p = 0.12; 6 h: F = 9.72, p = 1.54e-3; 8 h: F = 3.72, p = 0.05; 24 h: F = 0.62, p = 0.55).  459 
 460 
